Candel Therapeutics, Inc. ( ($CADL) ) has released its Q4 earnings. Here is a breakdown of the information Candel Therapeutics, Inc. presented to ...

Prelude Therapeutics Incorporated (Nasdaq: PRLD) has released its 2024 financial results and provided an update on its ...

Pope Francis, 88, was hospitalized last Friday with bronchitis, the Vatican said, and now has a “polymicrobial infection of ...

Epinephrine is the only proven anaphylaxis treatment to reduce the risk of hospitalization and death. However, only 21% of ...

A groundbreaking consensus report on anaphylaxis – the severe reaction some people experience from bee stings, peanut butter ...

In a regulatory filing, BioNTech (BNTX) disclosed that the U.S. Food and Drug Administration has informed BioNTech SE that it has placed a ...

PESG Research releases an update following groundbreaking clinical evaluation results: Inspira Technologies* (NASDAQ: IINN) ...

Highlighted potential long-term benefits of INB-200. As of October 18, 2024, five patients remained alive, three patients had ...

We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished ...

Final analysis from IGNITE Phase 2 clinical trial planned for second quarter of 2025: The Company plans to report the final ...